This material is only slightly soluble in water at a reported rate of 11.7 mg/L. The solubility of this product is tested in DMSO at a minimum rate of 20 mg/mL, with most lots soluble at 40 mg/mL. Other reported solvents include chloroform, ethanol, methanol and n-propanol. Following solubilization in any of the solvents listed above, stock solutions may typically be diluted with aqueous solvents or buffers.
F1293
Finasteride
≥98% (HPLC), Selective 5α-reductase inhibitor, powder
Sinónimos:
N-(2-methyl-2-propyl)-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide, N-tert-Butyl-3-oxo-4-aza-5α-androst-1-en-17β-carboxamide, MK-906
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
| A ustedes/SKU | Disponibilidad | Precio |
|---|---|---|
100 mg | Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad | 99,90 € |
Acerca de este artículo
Fórmula empírica (notación de Hill):
C23H36N2O2
Número CAS:
Peso molecular:
372.54
UNSPSC Code:
41116107
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
99,90 €
Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleNombre del producto
Finasteride, ≥98% (HPLC), powder
Quality Segment
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: soluble >20 mg/mL
storage temp.
room temp
SMILES string
[H][C@@]12CC[C@@]3([H])[C@]4([H])CC[C@H](C(=O)NC(C)(C)C)[C@@]4(C)CC[C@]3([H])[C@@]1(C)C=CC(=O)N2
InChI
1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1
InChI key
DBEPLOCGEIEOCV-WSBQPABSSA-N
Gene Information
human ... HSD3B1(3283), SRD5A1(6715), SRD5A2(6716)
rat ... Hsd3b1(360348), Srd5a1(24950), Srd5a2(64677)
Application
Finasteride has been used:
- as a component of L-15 media to investigate the effects of finasteride exposure on brain, liver and testis tissues
- in culture medium to treat tumor cells in vitro
- as a positive control to treat benign prostatic hyperplasia (BPH)
- to examine its effect on structural and molecular biology on the ventral prostate of senile mice
Biochem/physiol Actions
Finasteride can reduce serum and scalp dihydrotestosterone (DHT) by preventing the transformation of testosterone to DHT. It is usually used to manage benign prostate hyperplasia and pattern hair loss in male. Finasteride possesses androgen-distracting properties.
Selective 5α-reductase inhibitor; antiandrogen.
1 of 1
Este artículo | |||
|---|---|---|---|
| description ≥98% (HPLC), powder | description ≥98% (HPLC) | description ≥98% (HPLC) | description European Pharmacopoeia (EP) Reference Standard |
| form powder | form powder | form powder | form - |
| assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay - |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level - |
| storage temp. room temp | storage temp. −20°C | storage temp. 2-8°C | storage temp. 2-8°C |
| solubility DMSO: soluble >20 mg/mL | solubility DMSO: 2 mg/mL, clear | solubility DMSO: ≥15 | solubility - |
| color white to beige | color white to beige | color white to tan | color - |
Still not finding the right product?
Explore all of our products under Finasteride
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Repr. 1B
Clase de almacenamiento
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
-
Is this product soluble in distilled water? I need this information because I am planning a scientific experiment.
1 respuesta-
¿Le ha resultado útil?
-